Derailed endocytosis: An emerging feature of cancer

Yaron Mosesson, Gordon Mills, Yosef Yarden

Research output: Contribution to journalReview article

465 Citations (Scopus)

Abstract

Once engaged by soluble or matrix-anchored ligands, cell surface proteins are commonly sorted to lysosomal degradation through several endocytic pathways. Defective vesicular trafficking of growth factor receptors, as well as unbalanced recycling of integrin- and cadherin-based adhesion complexes, has emerged in the past 5 years as a multifaceted hallmark of malignant cells. In line with the cooperative nature of endocytic machineries, multiple oncogenic alterations underlie defective endocytosis, such as altered ubiquitylation (Cbl and Nedd4 ubiquitin ligases, for example), altered cytoskeletal interactions and alterations to Rab family members. Pharmaceutical interception of the propensity of tumour cells to derail their signalling and their adhesion receptors may constitute a novel target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)835-850
Number of pages16
JournalNature Reviews Cancer
Volume8
Issue number11
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Endocytosis
Growth Factor Receptors
Ubiquitination
Recycling
Cadherins
Ligases
Ubiquitin
Integrins
Neoplasms
Membrane Proteins
Ligands
Pharmaceutical Preparations
Therapeutics
adhesion receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Derailed endocytosis : An emerging feature of cancer. / Mosesson, Yaron; Mills, Gordon; Yarden, Yosef.

In: Nature Reviews Cancer, Vol. 8, No. 11, 01.11.2008, p. 835-850.

Research output: Contribution to journalReview article

Mosesson, Yaron ; Mills, Gordon ; Yarden, Yosef. / Derailed endocytosis : An emerging feature of cancer. In: Nature Reviews Cancer. 2008 ; Vol. 8, No. 11. pp. 835-850.
@article{446ccde7bf3b4d2895397be60089cf09,
title = "Derailed endocytosis: An emerging feature of cancer",
abstract = "Once engaged by soluble or matrix-anchored ligands, cell surface proteins are commonly sorted to lysosomal degradation through several endocytic pathways. Defective vesicular trafficking of growth factor receptors, as well as unbalanced recycling of integrin- and cadherin-based adhesion complexes, has emerged in the past 5 years as a multifaceted hallmark of malignant cells. In line with the cooperative nature of endocytic machineries, multiple oncogenic alterations underlie defective endocytosis, such as altered ubiquitylation (Cbl and Nedd4 ubiquitin ligases, for example), altered cytoskeletal interactions and alterations to Rab family members. Pharmaceutical interception of the propensity of tumour cells to derail their signalling and their adhesion receptors may constitute a novel target for cancer therapy.",
author = "Yaron Mosesson and Gordon Mills and Yosef Yarden",
year = "2008",
month = "11",
day = "1",
doi = "10.1038/nrc2521",
language = "English (US)",
volume = "8",
pages = "835--850",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Derailed endocytosis

T2 - An emerging feature of cancer

AU - Mosesson, Yaron

AU - Mills, Gordon

AU - Yarden, Yosef

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Once engaged by soluble or matrix-anchored ligands, cell surface proteins are commonly sorted to lysosomal degradation through several endocytic pathways. Defective vesicular trafficking of growth factor receptors, as well as unbalanced recycling of integrin- and cadherin-based adhesion complexes, has emerged in the past 5 years as a multifaceted hallmark of malignant cells. In line with the cooperative nature of endocytic machineries, multiple oncogenic alterations underlie defective endocytosis, such as altered ubiquitylation (Cbl and Nedd4 ubiquitin ligases, for example), altered cytoskeletal interactions and alterations to Rab family members. Pharmaceutical interception of the propensity of tumour cells to derail their signalling and their adhesion receptors may constitute a novel target for cancer therapy.

AB - Once engaged by soluble or matrix-anchored ligands, cell surface proteins are commonly sorted to lysosomal degradation through several endocytic pathways. Defective vesicular trafficking of growth factor receptors, as well as unbalanced recycling of integrin- and cadherin-based adhesion complexes, has emerged in the past 5 years as a multifaceted hallmark of malignant cells. In line with the cooperative nature of endocytic machineries, multiple oncogenic alterations underlie defective endocytosis, such as altered ubiquitylation (Cbl and Nedd4 ubiquitin ligases, for example), altered cytoskeletal interactions and alterations to Rab family members. Pharmaceutical interception of the propensity of tumour cells to derail their signalling and their adhesion receptors may constitute a novel target for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=54549102284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54549102284&partnerID=8YFLogxK

U2 - 10.1038/nrc2521

DO - 10.1038/nrc2521

M3 - Review article

C2 - 18948996

AN - SCOPUS:54549102284

VL - 8

SP - 835

EP - 850

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 11

ER -